↓ Skip to main content

Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer

Overview of attention for article published in Clinical Cancer Research, January 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
1 news outlet
twitter
58 X users
patent
2 patents

Citations

dimensions_citation
123 Dimensions

Readers on

mendeley
110 Mendeley